$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
10:26am, Wednesday, 21'st Jun 2023
You generally associate Super Bowl commercials with products made by PepsiCo Inc. NYSE: PEP or the Coca-Cola Co. NYSE: KO, but earlier this year, glucose-monitoring geat maker DexCom Inc. NASDAQ: DXCM
Dow Up 428 Points As Stocks Hits 2023 Highs; Chipotle, Dexcom, Hyatt Near Buy Points
05:15pm, Thursday, 15'th Jun 2023
The Dow Jones Industrial Average rallied 428 points Thursday, hitting a 2023 high. Chipotle is one of the stock market leaders to watch.
Frank Sands' Top 1st-Quarter Buys
03:57pm, Tuesday, 06'th Jun 2023
Sands Capital Management recently disclosed its 13F portfolio updates for the first quarter of 2023, which ended on March 31.
Have $1,500? 2 Top Growth Stocks to Buy and Hold for the Long Haul
05:30am, Tuesday, 06'th Jun 2023
The gig economy and diabetes care each represent rapidly-expanding total addressable markets. Fiverr isn't yet profitable, but its bottom line is improving as it grows its revenue and take rate.
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
07:45am, Saturday, 03'rd Jun 2023
Vertex Pharmaceuticals' main franchise has no competition, and it boasts several promising programs. DexCom's opportunities in the continuous glucose monitoring market make it an attractive long-term
2 Incredible Growth Stocks to Buy Before the Next Bull Market
09:37am, Wednesday, 31'st May 2023
Diabetes care and e-commerce are explosive industries set to see tremendous growth over the coming decade. DexCom is rolling out its latest product, and a new Medicare ruling should expand its total a
3 Stock-Split Stocks Billionaires Can't Stop Buying
05:06am, Wednesday, 31'st May 2023
Since early 2022, everyday investors and Wall Street's brightest billionaire money managers have flocked to stocks enacting splits. The sustained competitive advantages offered by three stock-split st
How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring
08:00am, Friday, 26'th May 2023
CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see the technology expanding.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
11:17am, Thursday, 25'th May 2023
Investors continue to be optimistic about DexCom (DXCM), owing to its strong product portfolio.
The Best Stocks to Invest $500 in Right Now
10:07am, Thursday, 25'th May 2023
Concerns about the economy linger among investors, but some companies could show resilience. DexCom is serving a constant and growing need with its continuous glucose monitoring devices.
Investing $1,000 in These 2 Top Growth Stocks Would Be a Brilliant Move
09:55am, Tuesday, 23'rd May 2023
Teladoc remains one of the best telehealth prospects despite a rough past 12 months. DexCom is still just scratching the surface of a large opportunity related to continuous glucose monitoring.
These stock pickers led the health-fund category over the past 5 years. Here's where they're investing now.
01:59pm, Monday, 22'nd May 2023
The Baron Health Care Fund's first five years have been exceptional in every sense of the word. Launched in spring 2018, the fund has navigated around the COVID-19 pandemic, a biotech initial public o
What Recession? These Companies Expect 20% Sales Growth This Year.
08:45am, Wednesday, 17'th May 2023
As more states legalize sports betting, DraftKings stock benefits from a greater pool of potential customers. DexCom's continuous glucose monitoring devices help diabetics keep track of their conditio
3 Stocks on the Verge of Breaking Out
09:55am, Monday, 15'th May 2023
Andrew Rocco combines fundamentals and technicals to bring you 3 top stocks on the verge of breaking out.
8 Stocks' Monster Profit Growth Can't Be Contained
08:00am, Monday, 15'th May 2023
Profits are down at S&P 500 companies at large. But a few are putting up monster profit gains that seem to have no bounds.
Sign In
Buy DXCM